Peter Sever Selected Research

Peter Sever Research Topics

Disease

18	Hypertension (High Blood Pressure) 01/2023 - 09/2006
10	Stroke (Strokes) 01/2023 - 09/2004
10	Myocardial Infarction 01/2023 - 09/2004
10	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 11/2009
7	Heart Failure 01/2023 - 09/2004
5	Essential Hypertension 01/2022 - 08/2004
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2015
4	Diabetes Mellitus 01/2021 - 08/2015
4	Coronary Disease (Coronary Heart Disease) 07/2016 - 09/2004
3	Atherosclerosis 01/2023 - 01/2019
2	Inflammation (Inflammations) 01/2023 - 01/2019
2	Hypotension (Low Blood Pressure) 07/2018 - 03/2013
1	Chronic Renal Insufficiency 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Edema (Dropsy) 01/2023
1	Flushing 01/2023
1	COVID-19 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Heart Diseases (Heart Disease) 12/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Injection Site Reaction 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Atrial Fibrillation 01/2021
1	Acute Coronary Syndrome 11/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020
1	Ascites 10/2020
1	Hyperaldosteronism (Conn Syndrome) 01/2018
1	Ciliopathies 01/2018
1	beta-Thalassemia (Cooley's Anemia) 12/2017
1	Macular Degeneration (Age-Related Maculopathy) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Erectile Dysfunction 06/2017
1	Hemic and Lymphatic Diseases 06/2017
1	Genetic Risk Score 03/2017
1	Myalgia 11/2016
1	Muscular Diseases (Myopathy) 11/2016
1	Rhabdomyolysis 11/2016
1	Vascular Diseases (Vascular Disease) 11/2016
1	Glucose Intolerance 02/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016

Drug/Important Bio-Agent (IBA)

8	LipidsIBA 12/2022 - 12/2006
8	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 09/2004
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2010
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2014
4	Amlodipine (Norvasc)FDA LinkGeneric 01/2023 - 09/2004
4	Angiotensin Receptor AntagonistsIBA 01/2022 - 09/2004
4	Atenolol (Tenormin)FDA LinkGeneric 01/2018 - 08/2004
4	Atorvastatin (Lipitor)FDA Link 01/2018 - 12/2006
4	DiureticsIBA 02/2016 - 08/2015
3	evolocumabIBA 01/2022 - 01/2021
3	CholesterolIBA 01/2022 - 06/2017
3	LDL CholesterolIBA 12/2021 - 11/2016
3	Amiloride (Midamor)FDA LinkGeneric 10/2020 - 02/2016
3	Spironolactone (Aldactone)FDA LinkGeneric 10/2020 - 11/2015
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018 - 09/2004
3	SodiumIBA 11/2015 - 10/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 02/2016
2	ThiazidesIBA 10/2020 - 02/2016
2	PotassiumIBA 10/2020 - 02/2016
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2020 - 08/2015
2	CreatinineIBA 07/2018 - 05/2017
2	ReninIBA 01/2018 - 08/2015
2	Renin InhibitorsIBA 02/2016 - 03/2013
1	InterleukinsIBA 01/2023
1	TroponinIBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	TicagrelorIBA 01/2021
1	darapladibIBA 01/2021
1	saxagliptin FDA Link 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2020
1	Long Noncoding RNAIBA 01/2019
1	CollagenIBA 01/2019
1	Natriuretic PeptidesIBA 01/2019
1	azilsartan medoxomilIBA 07/2018
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 07/2018
1	AldosteroneIBA 01/2018
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2018
1	SaltsIBA 01/2018
1	5'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA 01/2018
1	oxidized low density lipoproteinIBA 12/2017
1	Lipoproteins (Lipoprotein)IBA 12/2017
1	Fibric Acids (Fibrates)IBA 06/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2016
1	Immunoglobulin G (IgG)IBA 07/2016
1	Immunoglobulin M (IgM)IBA 07/2016
1	CatecholaminesIBA 04/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2016
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 02/2016

Therapy/Procedure

11	Therapeutics 01/2022 - 05/2012
1	Percutaneous Coronary Intervention 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022
1	Precision Medicine 03/2017
1	Secondary Prevention 11/2016